Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP
Clinical trial NCT06727357 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06727357
- Sponsor
- European Institute of Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2025-03-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.